Journal of Clinical Trails

Welcome to the Journal of Clinical Trials (JCT) - a peer-reviewed, open-access platform dedicated to advancing the science, ethics, and impact of clinical research across all areas of medicine and healthcare. As part of SCICONX Publishing’s mission to foster innovation and global collaboration, this journal serves as a critical hub for researchers, clinicians, regulators, and pharmaceutical professionals involved in the design, execution, and analysis of clinical investigations.

We aim to bridge the gap between scientific discovery and patient care by promoting high-quality, transparent, and reproducible studies that drive therapeutic advancements and evidence-based decision-making. The Journal of Clinical Trials welcomes original research articles, protocol papers, case series, meta-analyses, and regulatory insights from diverse clinical disciplines.

Whether you are conducting an early-phase human trial or evaluating real-world outcomes of interventions, our journal provides a trusted venue to disseminate your findings and contribute to the evolving landscape of clinical development and translational medicine.

✦ Key Focus Areas:

• Phase I–IV clinical trials
• Trial methodology and design innovations
• Adaptive and decentralized trial models
• Drug and vaccine development
• Device trials and surgical innovations
• Digital therapeutics and remote monitoring
• Bioethics, regulatory frameworks, and informed consent
• Patient-reported outcomes and quality of life research

✦ Fast Editorial Execution and Review Process (FEE-Review Process)

Authors who are willing to publish their articles under this mode can make a pre-payment of € 99 towards express peer-review and editorial decision. First editorial decision in 3 days and final decision with review comments in 5 days from the date of submission. Galley proof generation will be done in next 2 days from acceptance or maximum 5 days (For manuscripts notified for revision by external reviewer).

Manuscripts accepted for publication will be charged regular APC.

Authors retain the copyright of their publication and the final version of the article will be published in both HTML and PDF formats as well as XML formats for transmitting to indexing databases. The editorial team of the Journal will ensure adherence to scientific publication guidelines.

The Journal of Clinical Trials is committed to fast, fair, and rigorous peer review, ensuring that every published article meets the highest standards of scientific integrity and clinical relevance. We invite clinicians, researchers, CROs, academic institutions, and industry leaders to submit their work and become part of a forward-looking global clinical research community.

Submit your manuscript today and shape the future of patient-centered innovation. 

Now accepting inaugural submissions for our upcoming issue.